Actively Recruiting
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Led by Innovent Biologics (Suzhou) Co. Ltd. · Updated on 2023-11-29
182
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a phase 1/2 multicenter, open-label, first-in-human study of IBI130. It includes a phase 1 dose escalation and expansion section to identify MTD/RP2D of IBI130, plan to enroll 20\~182 subjects,and a phase 2 to explore efficacy, safety and tolerability of IBI130 at RP2D in specified types of solid tumor.Approximately 150 evaluable subjects will be enrolled for phase 2.
CONDITIONS
Official Title
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to understand and provide written informed consent for all study procedures
- Male or female aged 18 years or older
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Expected to live at least 12 weeks
- Adequate bone marrow and organ function
You will not qualify if you...
- Currently enrolled in other interventional clinical trials except observational or follow-up phases
- Received anti-tumor treatment within 4 weeks or 5 half-lives before starting study drug
- Planning to receive other anti-tumor therapies during this study except palliative radiotherapy for symptom relief without affecting tumor assessment
- Received live vaccines within 4 weeks before starting study drug or planning to receive live vaccines during the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sunshine Coast University
Birtinya, Queensland, Australia, 4575
Actively Recruiting
Research Team
S
Serena Dong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here